Palo Alto VA Medical Center
Palo Alto, California, 94304, United States
NCT Number: NCT07084116
The purpose of this research is to determine whether once nightly application of tretinoin 0.1% cream to forearm skin reduces the frequency of skin tears and bruising (solar purpura), and changes skin thickness over a period of 6 months.
Looking for future studies?
Notify Me55 year and older
All sexes
Interventional
Phase 2 / Phase 3
Palo Alto, California, 94304, United States
Easy bruising and tearing of forearm skin is common with aging and can cause activity restriction, infection, and pain. Chronic exposure to UV light from the sun causes skin thinning and loss of supportive collagen over time. Thin skin tears easily and blood vessels normally protected by collagen rupture, causing bruises. Tretinoin is a prescription vitamin A cream that has been shown to increase skin thickness and collagen. Tretinoin is FDA approved for treatment of acne. We are trying to figure out if putting tretinoin cream on the forearms of adults with thin skin prevents skin tears and bruising.
We are looking for 30 people with a history of skin tears in the United States. The VA Palo Alto expects to enroll 30 research study subjects.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Tretinoin 0.1% cream formulation.
Other names: Bland cream (non-medicated)
Bland cream formulation.
Time frame: 6 months.
Time frame: 6 months.
Time frame: 6 months.
James Thomas Pathoulas
Other
Evaluation of Tretinoin Cream on the Integrity of Aged Forearm Skin: an Open-label Within-subject Randomized Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03824886
Dermatitis, Dry Skin
Berlin, Germany
View Trial DetailsNCT05699980
Blood Coagulation Disorders, Dermatoporosis
Ancerville, France
View Trial DetailsNCT05092204
Dermatoporosis
Paris, France
View Trial DetailsNCT03998228
Dermatoporosis
Paris, France
View Trial Details